– USA, TX – Rapid Therapeutic Science Laboratories (OTC: RTSL), a growth-oriented aerosol manufacturing company focused on the delivery of non-psychoactive cannabinoid compounds, today announced the appointments of Dr. Henry Punzi (MD) and Justin Suggs to its Board as independent directors.
“The addition of Dr. Punzi and Mr. Suggs is an important step in the evolution of Rapid Therapeutic, as it adds important and diversified expertise to our Board in both the medical and practice management areas, but it also fulfills the important Nasdaq requirement of appointing independent Board members in order for us to up-list onto that major exchange,” said CEO, Donal Schmidt. “We welcome both gentlemen to our Company and look forward to the benefit of their guidance.”
About Dr. Henry Punzi
Henry Punzi, MD is a respected clinician and researcher. He currently serves as Medical Director, Clinical Trials at the Trinity Hypertension and Metabolic Institute, as well as an attending physician in the Internal Medicine Department at Carrollton Regional Medical Center, both in Carrollton, Texas. He is also Assistant Clinical Professor at the University of Texas Southwestern Medical School and an Associate Clinical Professor at Texas Women’s University, each in Dallas. Dr. Punzi has a 42-year history as a clinician, educator, and administrator, as well as experience within the pharmaceutical industry. He completed medical school at the University of Buenos Aires, Argentina, and completed his residency at University Hospital de Clinicas Jose de San Martin in Buenos Aires. He subsequently completed two fellowships, one in oncology/hematology at Wadley Institute of Molecular Medicine, Granville C. Morton Hospital, Dallas, Texas, and one in clinical and research hypertension at University of Texas Health Science Center, Southwestern Medical School, Parkland Memorial Hospital, Dallas, Texas. He also completed an executive MBA program at Texas Tech University.
About Scott Suggs
Scott Suggs is a skilled professional focused on process management and revenue growth with more than 27 years of professional management experience, primarily with medical and dental practices. Scott has a deep understanding of multi-market operational processes from new market entry to complex national growth strategies. He is president and owner of Suggs Pediatric Outpatient Services, as well as the founder and creator of two additional thriving businesses, S&S Transportation, which provides transportation services for heavy crude oil and frac sand in the oil and gas industry, and Suggs Transport which provides equipment lease services to the energy sector nationwide.
About Rapid Therapeutic Science Laboratories, Inc.
RTSL is a biopharmaceutical company that has developed a new method of formulating and manufacturing pressurized metered-dose inhalers that contain and properly aerosolize proprietary formula of one or more patent-pending pharmaceutical-grade cannabinoid compounds. RTSL has developed and is continuing to develop a series of complementary products in addition to its inhaler. The Company’s nhāler product line is manufactured in compliance with a good manufacturing process. The company is preparing to file an investigational new drug application with the FDA for its CBD MDI.
For more information: https://rtslco.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
